(MedPage Today) — SAN FRANCISCO — Despite a growing emphasis on quality-of-life (QoL) endpoints and patient-reported outcomes in cancer trials, the reporting of those results has been inconsistent for prostate, kidney, and bladder cancer trials…
Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/120127
Author :
Publish date : 2026-03-02 22:14:00
Copyright for syndicated content belongs to the linked Source.
